BRPI0821553A2 - Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico - Google Patents

Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico

Info

Publication number
BRPI0821553A2
BRPI0821553A2 BRPI0821553-7A2A BRPI0821553A BRPI0821553A2 BR PI0821553 A2 BRPI0821553 A2 BR PI0821553A2 BR PI0821553 A BRPI0821553 A BR PI0821553A BR PI0821553 A2 BRPI0821553 A2 BR PI0821553A2
Authority
BR
Brazil
Prior art keywords
peptide
tribe
dermatitis
release
nucleic acid
Prior art date
Application number
BRPI0821553-7A2A
Other languages
English (en)
Inventor
Burghard Liebmann
Heike Brueser
Heiko Barg
Daniel Huemmerich
Hubertus Peter Bell
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of BRPI0821553A2 publication Critical patent/BRPI0821553A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
BRPI0821553-7A2A 2007-12-21 2008-12-19 Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico BRPI0821553A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07024988 2007-12-21
EP08159834 2008-07-07
US8070508P 2008-07-15 2008-07-15
PCT/EP2008/010912 WO2009080306A1 (en) 2007-12-21 2008-12-19 Anti-dandruff compositions containing peptides

Publications (1)

Publication Number Publication Date
BRPI0821553A2 true BRPI0821553A2 (pt) 2014-10-07

Family

ID=40419487

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821553-7A2A BRPI0821553A2 (pt) 2007-12-21 2008-12-19 Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico

Country Status (9)

Country Link
US (1) US8765688B2 (pt)
EP (1) EP2224901A1 (pt)
JP (1) JP5688293B2 (pt)
KR (2) KR101425331B1 (pt)
CN (1) CN101903011B (pt)
BR (1) BRPI0821553A2 (pt)
CA (1) CA2708554C (pt)
RU (1) RU2491052C2 (pt)
WO (1) WO2009080306A1 (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101855239B (zh) * 2007-06-20 2013-11-06 巴斯夫欧洲公司 合成的重复蛋白及其生产和用途
BRPI0821553A2 (pt) * 2007-12-21 2014-10-07 Basf Se Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico
US20110136669A1 (en) * 2008-08-08 2011-06-09 Basf Se Continuous Fiber Layer Comprising an Active Substance on the Basis of Bio-Polymers, the use Thereof, and Method for the Production Thereof
WO2010015709A2 (de) * 2008-08-08 2010-02-11 Basf Se Wirkstoffhaltige fasernflächengebilde mit einstellbarer wirkstofffreisetzung, ihre anwendungen und verfahren zu ihrer herstellung
CA2735252A1 (en) * 2008-08-28 2010-03-04 The Procter & Gamble Company Fabric care compositions, process of making, and method of use
CN102458439A (zh) * 2009-05-15 2012-05-16 巴斯夫欧洲公司 包含抗真菌肽的药物组合物
JP5730293B2 (ja) * 2009-06-03 2015-06-10 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ ペプチドの組換え生成
EP2470008A2 (de) 2009-08-26 2012-07-04 Basf Se Verwendung von cycloaliphatischen diolen als biozide
BR112012004153A2 (pt) 2009-08-26 2016-03-22 Basf Se uso de um diol, corpo moldado biocidamente acabado, e, preparação líquida
DE102010062662A1 (de) * 2010-12-08 2012-06-14 Henkel Ag & Co. Kgaa Wirkstoffkombination und Haarbehandlungsmittel
FR2976799B1 (fr) * 2011-06-23 2013-07-26 Oreal Composition cosmetique comprenant au moins un polymere amphotere particulier et un agent antipelliculaire.
WO2013025765A2 (en) * 2011-08-15 2013-02-21 The Procter & Gamble Company Methods of reducing odor
DE102011087233A1 (de) * 2011-11-28 2013-05-29 Henkel Ag & Co. Kgaa Glanzbringendes Haarbehandlungsmittel
GB201204457D0 (en) * 2012-03-14 2012-04-25 Novabiotics Ltd Polypeptides and their use
CN104704127A (zh) * 2012-07-13 2015-06-10 莱雅公司 体外诊断受试者的薄皮状态的方法及相关应用
EP2931854A1 (en) 2012-12-14 2015-10-21 The Procter & Gamble Company Fragrance materials
MX2015012298A (es) * 2013-03-15 2015-12-16 Procter & Gamble Un metodo no invasivo para medir peptidos antimicrobianos de la piel como una medicion objetica de proteccion natural de los microbios.
EP3013433B1 (en) 2013-06-27 2019-04-17 The Procter and Gamble Company Preserving personal care compositions
KR101595440B1 (ko) * 2014-01-17 2016-02-18 조선대학교 산학협력단 Ｃｍ－ｍａ 펩타이드로부터 유래된 유사체 펩타이드 ｃｍａ３ 및 이의 용도
JP7066412B2 (ja) 2015-04-23 2022-05-13 ザ プロクター アンド ギャンブル カンパニー 界面活性剤可溶性抗ふけ剤の送達
CA3014923C (en) 2016-03-03 2021-10-19 Sean Michael Renock Aerosol antidandruff composition
CN108697910A (zh) * 2016-03-30 2018-10-23 宝洁公司 个人清洁组合物及其制备方法
MX2019003107A (es) 2016-10-21 2019-09-13 Procter & Gamble Productos de champu compactos y estables con baja viscosidad y agente reductor de viscosidad.
WO2018075855A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
US11141361B2 (en) 2016-10-21 2021-10-12 The Procter And Gamble Plaza Concentrated shampoo dosage of foam designating hair volume benefits
WO2018075836A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
US11154467B2 (en) 2016-10-21 2021-10-26 The Procter And Gamble Plaza Concentrated shampoo dosage of foam designating hair conditioning benefits
CN109862944A (zh) 2016-10-21 2019-06-07 宝洁公司 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型
WO2018075841A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
JP6945746B2 (ja) 2017-10-10 2021-10-06 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ サルフェートフリーの界面活性剤を含有するコンパクトなシャンプー組成物
JP2020536876A (ja) 2017-10-10 2020-12-17 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ アミノ酸系アニオン性界面活性剤及びカチオン性ポリマーを含むコンパクトシャンプー組成物
JP2020536885A (ja) 2017-10-10 2020-12-17 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 無機塩低含有の、サルフェートを含まないパーソナルクレンジング組成物
CN111201010A (zh) 2017-10-10 2020-05-26 宝洁公司 用呈泡沫形式的个人护理组合物处理毛发或皮肤的方法
WO2019126444A1 (en) 2017-12-20 2019-06-27 The Procter & Gamble Company Clear shampoo composition containing silicone polymers
EP3813774A1 (en) 2018-06-29 2021-05-05 The Procter & Gamble Company Low surfactant aerosol antidandruff composition
US20200129402A1 (en) * 2018-10-25 2020-04-30 The Procter & Gamble Company Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents
KR102265433B1 (ko) * 2019-08-20 2021-06-15 주식회사 케어젠 발모 촉진 활성을 갖는 펩타이드 및 이의 용도
JP7481470B2 (ja) 2020-02-27 2024-05-10 ザ プロクター アンド ギャンブル カンパニー 有効性及び美観が強化された硫黄含有フケ防止組成物
CN111781047A (zh) * 2020-07-03 2020-10-16 四川恒健生物科技有限公司 一种用于血液分析的溶血素及其制备方法、试剂
CN116568263A (zh) 2020-12-04 2023-08-08 宝洁公司 包含恶臭减少材料的毛发护理组合物
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
EP4129319A1 (en) * 2021-08-02 2023-02-08 Masarykova univerzita Pore-forming antimicrobial peptides
CN114983853A (zh) * 2022-06-16 2022-09-02 山东福瑞达生物股份有限公司 一种低粘稳定的d相乳液及其制备方法
CN116874613B (zh) * 2023-09-06 2023-11-17 南京华盖制药有限公司 一种广谱高效的抗菌多肽aph143及其制备方法和应用
CN116874614B (zh) * 2023-09-06 2023-11-17 南京华盖制药有限公司 一种具有高活性低裂解效果的抗菌多肽aph171及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2162125T3 (es) 1995-12-16 2001-12-16 Planton Gmbh Proteinas de vertebrados eficaces contra bacterias, hongos y virus y sus preparados cosmeticos.
JPH11106399A (ja) * 1997-10-01 1999-04-20 Morinaga Milk Ind Co Ltd ペプチド誘導体および抗真菌剤
WO2000032220A1 (en) * 1998-11-30 2000-06-08 Novozymes A/S Anti-dandruff composition comprising an antifungal polypeptide
FR2786689A1 (fr) * 1998-12-03 2000-06-09 Oreal Composition cosmetique ou dermatologique comprenant au moins un alkynyl carbamate et au moins un polyol
US20030143234A1 (en) * 1999-08-20 2003-07-31 Wenyuan Shi Anti-microbial targeting chimeric pharmaceutical
WO2002010195A2 (en) * 2000-08-02 2002-02-07 Theratechnologies Inc. Modified peptides with increased potency
JP2002253245A (ja) * 2001-02-28 2002-09-10 Toyota Central Res & Dev Lab Inc 融合タンパク質
KR20030013189A (ko) * 2001-08-07 2003-02-14 주식회사 코메드 파골세포 분화를 억제하는 펩타이드 ｐ1
KR100438416B1 (ko) * 2001-09-19 2004-07-02 학교법인조선대학교 Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물
US20050058689A1 (en) * 2003-07-03 2005-03-17 Reactive Surfaces, Ltd. Antifungal paints and coatings
CN1245418C (zh) * 2002-12-30 2006-03-15 上海高科联合生物技术研发有限公司 一组新的合成抗菌肽及其制备方法和应用
SE0401942D0 (sv) * 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
ITRM20040349A1 (it) * 2004-07-13 2004-10-13 Univ Siena Peptidi antibatterici e loro analoghi.
CN1896107A (zh) * 2006-06-13 2007-01-17 南京农业大学 类天蚕素a－马盖宁杂合基因工程抗菌肽
BRPI0821553A2 (pt) 2007-12-21 2014-10-07 Basf Se Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico
CN101302249B (zh) * 2008-06-24 2011-08-17 四川大学 一种自组装短肽及其在制备抗肿瘤药物中的应用

Also Published As

Publication number Publication date
RU2010129845A (ru) 2012-01-27
KR101417202B1 (ko) 2014-07-16
EP2224901A1 (en) 2010-09-08
KR20100101155A (ko) 2010-09-16
US20100310644A1 (en) 2010-12-09
RU2491052C2 (ru) 2013-08-27
CA2708554C (en) 2014-04-22
JP5688293B2 (ja) 2015-03-25
CN101903011B (zh) 2014-08-06
CN101903011A (zh) 2010-12-01
JP2011508728A (ja) 2011-03-17
WO2009080306A1 (en) 2009-07-02
WO2009080306A8 (en) 2011-02-24
KR20130083484A (ko) 2013-07-22
CA2708554A1 (en) 2009-07-02
US8765688B2 (en) 2014-07-01
KR101425331B1 (ko) 2014-08-01

Similar Documents

Publication Publication Date Title
BRPI0821553A2 (pt) Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico
CL2013000074A1 (es) Proteina de union con capacidad de unir un par de antigenos; acido nucleico que la codifica; vector; celula huesped; metodo de produccion; composicion farmaceutica que la comprende; conjugado que comprende dicha proteina de union; y sus usos.
BRPI0908021A2 (pt) Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica
BRPI1013640A2 (pt) composicao farmaceutica, metodos para o tratamento e usos dos mesmos
DK2300472T3 (da) Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf
AR092487A2 (es) Anticuerpos contra la angiopoyetina 2 humana
DK2297385T3 (da) Polymere sammensætninger, som omfatter polymælkesyre, og fremgangsmåder til fremstilling og anvendelse deraf
CL2013001282A1 (es) Sal succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxilico; composicion farmaceutica que la comprende y procesos para su preparacion.
BR112013011705A2 (pt) antígenos consensuais de próstata, molécula de ácido nucleico que os codificam e vacina e usos que os compreendem
BRPI0914549A2 (pt) produção, formulação de usos de formulações estáveis de proteína harpina líquidas
CL2013001831A1 (es) Proteina de enlace multivalente y multiespecifica que une a il-1 alfa y beta; conjugado que la comprende; acido nucleico que la codifica; vector; celula huesped; metodo de produccion; composicion farmaceutica que la comprende; y sus usos.
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
BRPI0918360A2 (pt) composto, composição farmacêutica e usos de um composto
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
EA201070421A1 (ru) Микрорибонуклеиновые кислоты
ZA201208336B (en) Controlled release pharmaceutical compositions of tapentadol
BR112014012681A2 (pt) polipeptídeo, métido para proporcionar um polipeptídeo, ácido nucleico, e, composição imunogênica
BR112013011868A2 (pt) compostos de pirimidina hidróxi amida como inibidores da proteína desacetilase, composição farmacêutica e uso dos referidos compostos
BRPI1006435A2 (pt) "moléculas de ácidos nucleicos e polipeptídeos da sintase do ácido graxo poli-insaturado, composições, métodos de produção e uso dos mesmos"
BRPI0816330A2 (pt) Composição de polipeptídeo, método para produzir composição de polipeptídeo, construção de polipeptídeo, método para produzir uma construção de polipeptídeo, construção de ácido nucleico, medicamento ou composição de vacina, método para produzir um medicamento ou composição de vacina, e uso da composição de polipeptídeo, de uma construção de polipeptídeo, de uma construção de ácido nucléico ou de um medicamento ou de composição de vacina
DK3287123T3 (da) Vandig farmaceutisk formulering af tapentadol til oral administration
BR112014010290A2 (pt) composição farmacêutica, métodos, composições e usos
CO6761351A2 (es) Polipéptidos que se enlazan a cxcr2
BR112012014962A2 (pt) métodos e composições para formulações líquidas e estáveis de fármacos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART. 8O COMBINADO COM ART. 13 E ART. 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.